The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krylov N.N.

Sechenov First Moscow State Medical University (Sechenov University)

Kazhlaev A.Yu.

Sechenov First Moscow State Medical University (Sechenov University)

Karpenko I.V.

Sechenov First Moscow State Medical University (Sechenov University)

Batoev S.D.

Sechenov First Moscow State Medical University (Sechenov University)

In searching for perfect blood substitute. Creation and application of perftorane

Authors:

Krylov N.N., Kazhlaev A.Yu., Karpenko I.V., Batoev S.D.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2024;(2): 111‑117

DOI: 10.17116/hirurgia2024021111

Read: 3007 times

Contact the author
Table of contents

IN SEARCHING FOR PERFECT BLOOD SUBSTITUTE. CREATION AND APPLICATION OF PERFTORANE
IN SEARCHING FOR PERFECT BLOOD SUBSTITUTE. CREATION AND APPLICATION OF PERFTORANE

To cite this article:

Krylov NN, Kazhlaev AYu, Karpenko IV, Batoev SD. In searching for perfect blood substitute. Creation and application of perftorane. Pirogov Russian Journal of Surgery. 2024;(2):111‑117. (In Russ.)
https://doi.org/10.17116/hirurgia2024021111

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The article is devoted to historiography of perfluorocarbons, as well as discoverers of perftorane and their discoveries. There would be no national priority in transfusiology without these discoveries. Perftorane is the only one of the world series of perfluorocarbon emulsion drugs that has passed all phases of clinical trials. Perftorane has been used in clinical medicine for 30 years.

Keywords:

perfluorocarbons
perftorane
clinical application

Authors:

Krylov N.N.

Sechenov First Moscow State Medical University (Sechenov University)

Kazhlaev A.Yu.

Sechenov First Moscow State Medical University (Sechenov University)

Karpenko I.V.

Sechenov First Moscow State Medical University (Sechenov University)

Batoev S.D.

Sechenov First Moscow State Medical University (Sechenov University)

Received:

17.10.2023

Accepted:

15.11.2023

Close metadata

References:

  1. Fabian TC. Perfluorocarbons. The Journal of Trauma. 2011;70(5 suppl):42-44.  https://doi.org/10.1097/TA.0b013e31821a5a3f
  2. Latson GW. Perftoran (Vidaphor)-Introduction to Western Medicine. Shock. 2019;52(1S suppl 1):65-69.  https://doi.org/10.1097/SHK.0000000000001063
  3. Kylstra JA, Tissing MOo, van der Maen. Of mice as fish. Transactions of the American Society for Artificial Internal Organs. 1962;8:378-383.  https://doi.org/10.1097/00002480-196204000-00077
  4. Clark LC Jr, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 1966;152(3730):1755-1756. https://doi.org/10.1126/science.152.3730.1755
  5. Gollan F, Clark L. Organ perfusion with fluorocarbon. Physiologist. 1966;9:191. 
  6. Sloviter HA, Kamimoto T. Erythrocyte Substitute for Perfusion of Brain. Nature. 1967;216:458-460. 
  7. Geyer RP, Monroe RG, Taylor K: Survival of rats totally perfused with a fluorocarbon-detergent preparation. In: Organ Perfusion and Preservation. Norman J.C., Folkman J., Hardison W.G., Rudolf L.E., Veith F.J., eds. New York: Appleton-Cen-tury-Crofts; 1968;85-96. 
  8. Honda K, Hoshino S, Shoji M, Usuba A, Motoki R, Tsuboi M, Inoue H, Iwaya F. Clinical use of a blood substitute. The New England Journal of Medicine. 1980;303(7):391-392.  https://doi.org/10.1056/NEJM198008143030710
  9. Suyama T, Yokoyama K, Naito R. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)-an overview of clinical studies with 185 patients. Progress in clinical and biological research. 1981;55:609-628. 
  10. Maevskii EI. Possible causes of acute reactogenicity of perfluorocarbon emulsions. Part 1. Perfluorane. Proceedings of the Institute of Engineering Physics. 2016;1(39):79-87. (In Russ.).
  11. Интервью с мамой А. Гришиной. Личный архив автора. Personal Communication, August 2023. (In Russ.).
  12. Krylov HL, Moroz VV, Beloyartsev FF. The use of fluorocarbon blood substitute perfluorane in the clinic. Military Medical Journal. 1985;306(8):36-40. (In Russ.).
  13. Chen HS, Yang ZH. Perfluorocarbon as blood substitute in clinical applications and in war casualties. Biomaterials, artificial cells, and artificial organs. 1988;16:403-409. 
  14. Monk TG, Winston RS, Wahr JA, et al.: Perflubron emulsion is more effective than blood for transfusion trigger reversal [Abstract]. Anesth Analg. 1998;86(suppl):142. 
  15. Spahn DR, van Brempt R, Theilmeier G, Reibold JP, Welte M, Heinzerling H, Birck KM, Keipert PE, Messmer K, Heinzerling H, Birck KM, Keipert PE, Messmer K. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Anesthesiology. 1999;91(5):1195-1208. https://doi.org/10.1097/00000542-199911000-00009
  16. Spence RK, McCoy S, Costabile J, Norcross ED, Pello MJ, Alexander JB, Wisdom C, Camishion RC. Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients. Critical Care Medicine. 1990;18(11):1227-1230. https://doi.org/10.1097/00003246-199011000-00008
  17. Moroz VV, Krylov NL, Ivanitsky GR, Kaydash AN, Onishchenko NA, Simanov VA, Vorobyov SI. Application of perftoran in clinical medicine. Anesthesiology and resuscitation. Application. Alternatives to blood transfusions in surgery. M.: Medicine; 1999;126-135. (In Russ.).
  18. Maevskii EI, Aksenova OG, Bogdanova LA, Moroz VV, Senina RYa, Pushkin SYu, Ivanitsky GR. Analysis of side effects and clinical effects during phase 1 and 2 clinical trials of perfluorane. Bulletin of the Russian Blood Service. 2001;4:23-29. (In Russ.).
  19. Krichevskii AL. Compression injury of soft tissues. Guidelines for doctors. Krichevsky A.L., ed. Kemerovo: Kuzbassmedkat; 2005;333. (In Russ.).
  20. Vecherko AV, Glushchenko YuI, Zaraev AA, Filina NG, Shkuropatov YuF, Bondar OG. The use of perfluorane in medical practice (according to the results of the questionnaire). Transfusiology. 2003;1(4):54-56. (In Russ.).
  21. Maevsky E, Ivanitsky G, Bogdanova L, Axenova O, Karmen N, Zhiburt E, Senina R, Pushkin S, Maslennikov I, Orlov A, Marinicheva I. Clinical results of Perftoran application: present and future. Artificial Cells, Blood Substitutes, and. Immobilization Biotechnology. 2005;33(1):37-46.  https://doi.org/10.1081/bio-200046654
  22. Verdin-Vasquez RC, Zepeda-Perez C, Ferra-Ferrer R, Chavez-Negrete A, Contreras F, Barroso-Aranda J. Use of perftoran emulsion to decrease allogeneic blood transfusion in cardiac surgery: clinical trial. Artificial Cells, Blood Substitutes, and. Immobilization Biotechnology. 2006;34(4):433-454.  https://doi.org/10.1080/10731190600683969
  23. Lowe KC. Chapter 25 — Fluosol: The First Commercial Injectable Perfluorocarbon Oxygen Carrier. In: Blood Substitutes. Winslow RM, ed. Academic Press; 2006;276-287.  https://doi.org/10.1016/b978-012759760-7/50034-2
  24. Khan F, Singh K, Friedman MT. Artificial Blood: The History and Current Perspectives of Blood Substitutes. Discoveries. 2020;8(1):e104. https://doi.org/10.15190/d.2020.1
  25. Dvornikov MV, Medenkov AA, Frantsuzov VN. Development of new technologies to save the lives of the wounded and sick. Aerospace medicine, psychology and ergonomics. 2020;1:76-83. (In Russ.).
  26. Mayevsky EI, Golovnenkova AE, Alekseev SV, Kaptsov AV, Bogdanova LA. Perftoran. The untapped potential of medicine against COVID-19. Medline.ru. 2020;21:854-869. (In Russ.).
  27. Интервью с членом-корреспондентом РАН Г.Р. Иваницким. Личный архив автора. Personal Communication, Mart 2023. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.